youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
AVH:ASX
AVITA Medical Inc
A$4.32
arrow_downward
-2.26%(-0.100) 1D
Nov 3, 4:10:15 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AVH...
Open
A$4.42
High
A$4.42
Low
A$4.25
Mkt. cap
672.91M
Avg. vol.
393.07K
Volume
379.11K
52-wk high
A$4.75
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
Open
A$4.42
High
A$4.42
Low
A$4.25
Mkt. cap
672.91M
Avg. vol.
393.07K
Volume
379.11K
52-wk high
A$4.75
52-wk low
A$1.00
Shares outstanding
30.93M
No. of employees
226
News stories
From web sources and news partners
Investing.com
·
48 minutes ago
TD Cowen raises Avita Medical stock price target on growth outlook
Kalkine
·
17 hours ago
AVITA Medical Issues 387,716 Shares to Perceptive via Cashless Warrant Exercise
Kalkine
·
17 hours ago
Avita Medical Issues 387,716 Common Stock Shares After Perceptive Warrant Cashless Exercise on 29 October 2026
TradingView
·
19 hours ago
AVITA Medical Issues 387,716 Shares After Perceptive Warrant Exercise
Profile
Avita Medical is a clinical and commercial company developing and marketing a range of regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are PermeaDerm, a transparent, biosynthetic bilayer wound matrix used for temporary wound coverage after surgical excision of burns or trauma, and Cohealyx, a bovine-derived collagen dermal matrix used by burn and trauma surgeons to treat severe wounds and full-thickness burns by accelerating blood vessel formation in order to prepare damaged wound beds for skin autografts. Wikipedia
About AVITA Medical Inc
CEOJames Corbett
Employees226
Founded1999
HeadquartersValencia, California, United States
SectorBiotechnology
Websiteavitamedical.com